Switch theme
Sign up to access all valuation multiples
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
2019
7K+
LTM Revenue $757M
LTM EBITDA $58.6M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Pennant Group has a last 12-month revenue (LTM) of $757M and a last 12-month EBITDA of $58.6M.
In the most recent fiscal year, Pennant Group achieved revenue of $695M and an EBITDA of $44.4M.
Pennant Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Pennant Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $757M | XXX | $695M | XXX | XXX | XXX |
| Gross Profit | $152M | XXX | $93.8M | XXX | XXX | XXX |
| Gross Margin | 20% | XXX | 13% | XXX | XXX | XXX |
| EBITDA | $58.6M | XXX | $44.4M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 6% | XXX | XXX | XXX |
| EBIT | $53.8M | XXX | $37.4M | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $29.4M | XXX | $22.6M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Pennant Group's stock price is $29.
Pennant Group has current market cap of $990M, and EV of $1.3B.
See Pennant Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $990M | XXX | XXX | XXX | XXX | $1.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Pennant Group has market cap of $990M and EV of $1.3B.
Pennant Group's trades at 1.9x EV/Revenue multiple, and 29.6x EV/EBITDA.
Equity research analysts estimate Pennant Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pennant Group has a P/E ratio of 33.7x.
See valuation multiples for Pennant Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $990M | XXX | $990M | XXX | XXX | XXX |
| EV (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 22.5x | XXX | 29.6x | XXX | XXX | XXX |
| EV/EBIT | 24.5x | XXX | 35.2x | XXX | XXX | XXX |
| EV/Gross Profit | 8.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 33.7x | XXX | 43.9x | XXX | XXX | XXX |
| EV/FCF | 59.6x | XXX | 43.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPennant Group's last 12 month revenue growth is 15%
Pennant Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $8K for the same period.
Pennant Group's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pennant Group's rule of X is 45% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Pennant Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 47% | XXX | XXX | XXX |
| Rule of 40 | 21% | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 45% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pennant Group acquired XXX companies to date.
Last acquisition by Pennant Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Pennant Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Pennant Group founded? | Pennant Group was founded in 2019. |
| Where is Pennant Group headquartered? | Pennant Group is headquartered in United States of America. |
| How many employees does Pennant Group have? | As of today, Pennant Group has 7K+ employees. |
| Who is the CEO of Pennant Group? | Pennant Group's CEO is Mr. Brent J. Guerisoli. |
| Is Pennant Group publicy listed? | Yes, Pennant Group is a public company listed on NAS. |
| What is the stock symbol of Pennant Group? | Pennant Group trades under PNTG ticker. |
| When did Pennant Group go public? | Pennant Group went public in 2019. |
| Who are competitors of Pennant Group? | Similar companies to Pennant Group include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Pennant Group? | Pennant Group's current market cap is $990M |
| What is the current revenue of Pennant Group? | Pennant Group's last 12 months revenue is $757M. |
| What is the current revenue growth of Pennant Group? | Pennant Group revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Pennant Group? | Current revenue multiple of Pennant Group is 1.7x. |
| Is Pennant Group profitable? | Yes, Pennant Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pennant Group? | Pennant Group's last 12 months EBITDA is $58.6M. |
| What is Pennant Group's EBITDA margin? | Pennant Group's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Pennant Group? | Current EBITDA multiple of Pennant Group is 22.5x. |
| What is the current FCF of Pennant Group? | Pennant Group's last 12 months FCF is $22.1M. |
| What is Pennant Group's FCF margin? | Pennant Group's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Pennant Group? | Current FCF multiple of Pennant Group is 59.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
